In a study in which juvenile dogs received lisdexamfetamine dimesylate for 6 months beginning at 10 weeks of age, decreased bodyweight gain was seen at all doses tested (2, 5, and 12 mg/kg/day, which are approximately 0.5, 1, and 3 times the maximum recommended human daily dose on a mg/m2 basis for a child)
A low count may result in a variety of inflammatory diseases like cardiovascular and bowel disease, plus diabetes, arthritis, and cancer, according to a review published in Oncotarget (2)
Gordon: Thank you, Rhonda
There is no reason to expect retatrutide to perform better on this metric without deliberate intervention
If the reactions are particularly bothersome, your healthcare provider may want to try lowering your dose or switching you to another GLP-1 medication
Some book a weekly series before a big event